nivolumab,cc-122,cc-99282,durvalumab,ibrutinib,cc-220,relatlimab
astrazeneca,abbvie,janssen,bms
[]
happy to share the final results of plataformb study best poster! ctdna ngs combined analysis of trunk and resistant mutations after only 2 cycles of ct+cetuxi is the best predictor of response to treatment
#esmo2022 
medical oncologist @hospitaldelmar